Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee

December 14, 2005



The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

RotaTeq™ (rotavirus vaccine, live, oral, pentavalent), Rosemary Tiernan, MD MPH (HTM) (PPT)

Intussusception Following Use of RotaShield, A Summary, Hector Izurieta, FDA (HTM) (PPT)

RotaTeq™ (rotavirus vaccine, live, oral, pentavalent), Merck & Co., Inc. (PDF) (PPT)

Errata (PDF) (PPT)

Open Public Hearing

Observational comparision of Vaccine Errectiveness Against CDC-ILI in Adults Age 18-64 Years in the 1997-98 Season When the Variant Strain A/Sydney H3N2 Circulated (HTM) (PPT)